SMTL ID : 3w12.1

Insulin receptor ectodomain construct comprising domains L1-CR in complex with high-affinity insulin analogue [D-PRO-B26]-DTI-NH2, alpha-CT peptide(704-719) and FAB 83-7

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 4.30 Å
Oligo State
hetero-1-1-1-1-1-1-mer
Ligands
1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Menting, J.G. et al., How insulin engages its primary binding site on the insulin receptor. Nature (2013)
Release Date
2013-01-09
Peptides
Insulin receptor domains L1-CR: A
monoclonal antibody fab 83-7 fragment - heavy chain: B
monoclonal antibody fab 83-7 fragment - light chain: C
Insulin A chain: D
Insulin B chain: E
Insulin receptor alpha-CT peptide: F
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
E
B
C
C
D
D
A
E
B
F
F

Insulin receptor domains L1-CR

monoclonal antibody fab 83-7 fragment - heavy chain

monoclonal antibody fab 83-7 fragment - light chain

Insulin A chain

Insulin B chain

Insulin receptor alpha-CT peptide

Related Entries With Identical Sequence

1a7f.1 | 1ai0.1 | 1aiy.1 | 1b17.1 | 1b17.2 | 1b17.3 | 1b18.1 | 1b18.2 | 1b18.3 | 1b19.1 | 1b19.2 | 1b19.3 | 1b2a.1 | 1b2a.2 | 1b2a.3 | 1b2b.1 | 1b2b.2 | 1b2b.3 | 1b2c.1 | 1b2c.2 | 1b2d.1 | 1b2d.2 | 1b2d.3 | 1b2e.1 | 1b2e.2 | 1b2e.3 | 1b2f.1 | 1b2f.2 | 1b2g.1 | 1b9e.1  more...